Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT01746849 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01746849
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Multiple Myeloma Myelodysplastic Syndrome Non-Hodgkin's Lymphoma

Start date: 2012-12-01
Primary completion: 2026-12-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.